Actinium Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATNM and other ETFs, options, and stocks.About ATNM
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. It also develops and markets medicines for relapsed or refractory cancer patients.
CEOSandesh Seth
CEOSandesh Seth
Employees37
Employees37
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2000
Founded2000
Employees37
Employees37
ATNM Key Statistics
Market cap43.57M
Market cap43.57M
Price-Earnings ratio-1.24
Price-Earnings ratio-1.24
Dividend yield—
Dividend yield—
Average volume259.48K
Average volume259.48K
High today$1.44
High today$1.44
Low today$1.39
Low today$1.39
Open price$1.42
Open price$1.42
Volume57.97K
Volume57.97K
52 Week high$2.41
52 Week high$2.41
52 Week low$1.03
52 Week low$1.03
Stock Snapshot
As of today, Actinium Pharmaceuticals(ATNM) shares are valued at $1.43. The company's market cap stands at 43.57M, with a P/E ratio of -1.24.
As of 2025-11-29, Actinium Pharmaceuticals(ATNM) stock has fluctuated between $1.39 and $1.44. The current price stands at $1.43, placing the stock +2.9% above today's low and -0.7% off the high.
The Actinium Pharmaceuticals(ATNM)'s current trading volume is 57.97K, compared to an average daily volume of 259.48K.
In the last year, Actinium Pharmaceuticals(ATNM) shares hit a 52-week high of $2.41 and a 52-week low of $1.03.
In the last year, Actinium Pharmaceuticals(ATNM) shares hit a 52-week high of $2.41 and a 52-week low of $1.03.
People also own
Based on the portfolios of people who own ATNM. This list is generated using Robinhood data, and it’s not a recommendation.